chrX-641092-C-G
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_000451.4(SHOX):c.633+5C>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000663 in 1,613,550 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 50 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_000451.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SHOX | NM_000451.4 | c.633+5C>G | splice_region_variant, intron_variant | ENST00000686671.1 | NP_000442.1 | |||
SHOX | NM_006883.2 | c.633+5C>G | splice_region_variant, intron_variant | NP_006874.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SHOX | ENST00000686671.1 | c.633+5C>G | splice_region_variant, intron_variant | NM_000451.4 | ENSP00000508521.1 | |||||
SHOX | ENST00000381575.6 | c.633+5C>G | splice_region_variant, intron_variant | 1 | ENSP00000370987.1 | |||||
SHOX | ENST00000381578.6 | c.633+5C>G | splice_region_variant, intron_variant | 5 | ENSP00000370990.1 | |||||
SHOX | ENST00000334060.8 | c.633+5C>G | splice_region_variant, intron_variant | 5 | ENSP00000335505.3 |
Frequencies
GnomAD3 genomes AF: 0.000315 AC: 48AN: 152146Hom.: 0 Cov.: 32 AF XY: 0.000296 AC XY: 22AN XY: 74318
GnomAD3 exomes AF: 0.000104 AC: 26AN: 251140Hom.: 0 AF XY: 0.0000958 AC XY: 13AN XY: 135736
GnomAD4 exome AF: 0.0000404 AC: 59AN: 1461286Hom.: 0 Cov.: 33 AF XY: 0.0000385 AC XY: 28AN XY: 726940
GnomAD4 genome AF: 0.000315 AC: 48AN: 152264Hom.: 0 Cov.: 32 AF XY: 0.000296 AC XY: 22AN XY: 74446
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Feb 20, 2023 | Variant summary: SHOX c.633+5C>G alters a nucleotide located close to a canonical splice site and therefore could affect mRNA splicing. Several computational tools predict the variant strengthens the canonical 5 donor site. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.0001 in 251140 control chromosomes, predominantly at a frequency of 0.0014 within the African or African-American subpopulation in the gnomAD database. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 5.6 fold of the estimated maximal expected allele frequency for a pathogenic variant in SHOX causing Leri-Weill Dyschondrosteosis phenotype (0.00025), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. To our knowledge, no occurrence of c.633+5C>G in individuals affected with Leri-Weill Dyschondrosteosis and no experimental evidence demonstrating its impact on protein function have been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. One laboratory classified the variant as benign. Based on the evidence outlined above, the variant was classified as benign. - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Apr 12, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at